K.H. Lu

1.8k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

K.H. Lu is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K.H. Lu has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K.H. Lu's work include Reproductive Biology and Fertility (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer therapeutics and mechanisms (3 papers). K.H. Lu is often cited by papers focused on Reproductive Biology and Fertility (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer therapeutics and mechanisms (3 papers). K.H. Lu collaborates with scholars based in United States, Ireland and China. K.H. Lu's co-authors include Ian Gordon, Mary E. Gallagher, Shao‐Jing Tan, Bryan T. Hennessy, Thomas C. Krivak, Victor Abkevich, Liesel M. FitzGerald, Alexander Gutin, Thuan Van Tran and Lisa Meyer and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

In The Last Decade

K.H. Lu

32 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

2012 494 citations Victor Abkevich, Kirsten M. Timms et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.H. Lu United States	14	545	541	473	457	328	35	1.3k
Jian Hou China	15	77 0.1×	208 0.4×	487 1.0×	91 0.2×	96 0.3×	105	760
Kasper Langebjerg Andersen Denmark	10	60 0.1×	96 0.2×	418 0.9×	283 0.6×	214 0.7×	17	938
Teemu D. Laajala Finland	17	150 0.3×	38 0.1×	457 1.0×	119 0.3×	210 0.6×	44	987
Jenny Gross United States	10	250 0.5×	34 0.1×	471 1.0×	424 0.9×	152 0.5×	13	928
Lidija Beketić-Orešković Croatia	13	101 0.2×	96 0.2×	288 0.6×	276 0.6×	53 0.2×	37	591
Marc Hirschfeld Germany	19	89 0.2×	43 0.1×	656 1.4×	112 0.2×	41 0.1×	45	905
Nicola Cresti United Kingdom	13	215 0.4×	225 0.4×	216 0.5×	331 0.7×	80 0.2×	34	639
Steinunn Thorlacius Iceland	19	150 0.3×	228 0.4×	943 2.0×	713 1.6×	1.3k 3.9×	24	2.1k
Lin Gu China	16	107 0.2×	35 0.1×	274 0.6×	100 0.2×	80 0.2×	48	725
Angelita G. Utleg United States	10	101 0.2×	33 0.1×	441 0.9×	76 0.2×	67 0.2×	10	646

Countries citing papers authored by K.H. Lu

Since Specialization

Citations

This map shows the geographic impact of K.H. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.H. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.H. Lu more than expected).

Fields of papers citing papers by K.H. Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.H. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.H. Lu. The network helps show where K.H. Lu may publish in the future.

Co-authorship network of co-authors of K.H. Lu

This figure shows the co-authorship network connecting the top 25 collaborators of K.H. Lu. A scholar is included among the top collaborators of K.H. Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.H. Lu. K.H. Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, K.H., Nora Bruns, Adela Della Marina, et al.. (2024). Pediatric Community-Acquired Brain Abscesses: A Single-center Retrospective Study. The Pediatric Infectious Disease Journal. 43(6). e214–e217.

Yan, Fangrong, Peter F. Thall, K.H. Lu, Mark R. Gilbert, & Ying Yuan. (2017). Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding. Annals of Oncology. 29(3). 694–699. 62 indexed citations

Yates, Melinda S., Kirsten M. Timms, Molly S. Daniels, et al.. (2014). Next Generation Sequencing of Brca1/2 in High Grade Ovarian Tumors Expands Brca Defects Beyond Germline Mutations. Annals of Oncology. 25. iv308–iv308. 4 indexed citations

Holman, Laura L., Sue Friedman, Molly S. Daniels, Charlotte C. Sun, & K.H. Lu. (2013). Acceptability of salpingectomy alone as risk-reducing surgery for BRCA mutation carriers. Gynecologic Oncology. 130(1). e104–e104. 2 indexed citations

Ring, Kari L., et al.. (2013). Endometrial cancer screening in Lynch syndrome: Do patients report symptoms prior to diagnosis?. Gynecologic Oncology. 130(1). e100–e101. 1 indexed citations

Abkevich, Victor, Kirsten M. Timms, Bryan T. Hennessy, et al.. (2012). Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. British Journal of Cancer. 107(10). 1776–1782. 494 indexed citations breakdown →

Zhang, Q., Jian‐Hua Mao, Anja Weise, et al.. (2010). An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis. Oncogene. 29(18). 2659–2671. 19 indexed citations

Slomovitz, Brian M., Lois M. Ramondetta, Taren Johnston, et al.. (2007). A phase I study of imatinib mesylate and paclitaxel in patients with advanced (stage IIIC/IV) or recurrent uterine papillary serous carcinoma (UPSC). Journal of Clinical Oncology. 25(18_suppl). 16025–16025. 3 indexed citations

Lu, K.H., et al.. (2005). Future challenges in clinical and translational research for endometrial cancer. International Journal of Gynecological Cancer. 15(2). 398–411. 2 indexed citations

10.

Slomovitz, Brian M., Lois M. Ramondetta, Patricia J. Eifel, et al.. (2005). Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. International Journal of Gynecological Cancer. 15(3). 510–516. 10 indexed citations

11.

Slomovitz, Brian M., Russell R. Broaddus, Pamela T. Soliman, et al.. (2004). mTOR inhibition is a rational target for the treatment of endometrial cancer. Journal of Clinical Oncology. 22(14_suppl). 5076–5076. 7 indexed citations

12.

Lu, K.H., et al.. (1992). Vitrification of bovine blastocysts produced in vitro. Theriogenology. 37(1). 326–326. 20 indexed citations

13.

Lu, K.H., et al.. (1992). Examination of cell numbers of blastocysts derived from IVM, IVF and IVC of bovine follicular oocytes. Theriogenology. 37(1). 229–229. 31 indexed citations

14.

Lu, K.H., et al.. (1990). In vitro fertilization (IVF) and culture (IVC) of bovine oocytes from stored ovaries. Theriogenology. 33(1). 352–352. 72 indexed citations

15.

Lu, K.H., et al.. (1989). Birth of calves after in vitro maturation and fertilization of follicular oocytes. Theriogenology. 31(1). 222–222. 10 indexed citations

16.

Raber, Martin N., Robert A. Newman, K.H. Lu, et al.. (1989). Phase I clinical trial and pharmacokinetic evaluation of 4?-0-tetrahydropyranyladriamycin (THP-adriamycin). Cancer Chemotherapy and Pharmacology. 23(5). 311–315. 15 indexed citations

17.

McLean, Mark A., Marvin L. Vestal, K.H. Lu, et al.. (1987). Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.. Drug Metabolism and Disposition. 15(6). 773–778. 30 indexed citations

18.

Lu, K.H., et al.. (1987). Pregnancy established in cattle by transfer of embryos derived from in vitro fertilisation of oocytes matured in vitro. Veterinary Record. 121(11). 259–260. 188 indexed citations

19.

Savaraj, Niramol, K.H. Lu, & Lynn G. Feun. (1985). Interaction of [3H]homoharringtonine (HHT) with the calcium antagonist receptor in the rat. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations

20.

Lu, K.H., et al.. (1982). High-Performance Liquid Chromatography (HPLC) of the New Antineoplastic 9,10-Anthracenedicarboxaldehyde Bis[(4,5-Dihydro-1 H-Imidazole-2-yl)hydrazone] dihydrochloride (CL 216,942; Bisantrene). Journal of Liquid Chromatography. 5(7). 1323–1328. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact